Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. engages in the research and development, manufacture, and sale of packaging materials for the injectable pha...
In the year, important shareholders increased their holdings by over 93 billion yuan, setting a new high since 2023
HUALAN NPM newly established a smart pharmaceutical technology company, including AI business
HUALAN NPM released its performance for the first three quarters, with a net profit attributable to the parent company of 53.316 million yuan, an increase of 2.06%
HUALAN NPM: Net profit in the third quarter was 9.5839 million yuan, a year-on-year decrease of 37.20%
HUALAN NPM plans to establish a subsidiary in Hainan with an investment of 50 million yuan, focusing on research and development solutions and services for innovative drugs in artificial intelligence
HUALAN NPM established Nanjing Renqing Mianqu Health Technology Co., Ltd